Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 394 results for "Tecfidera"

Biogen Idec: A Great Company, But Not An Alpha Opportunity
Seeking Alpha

Biogen Idec Jumps as 2015 Profit Forecast Surpasses Estimates

(Bloomberg) -- Biogen Idec Inc., the maker of multiple sclerosis drugs including Tecfidera and Tysabri, surged in late trading on a 2015 profit forecast that surpassed analysts estimates. Adjusted earnings will reach $16.60 to $17 a share this ... Washington Post, 1 month ago
[x]  

3 images for "Tecfidera"

Pharma Letter, 2 weeks ago
Nasdaq, 2 weeks ago
Nasdaq, 1 month ago
InvestorPlace.com

Biogen Idec Inc Earnings: Worth the Wait

Going into the release, there was worry that growth of Tecfidera, Biogen's oral multiple sclerosis drug, was slowing down, especially in the U.S., but that doesn't really seem to be as big of a problem as investors feared. There was one extra ...
 Motley Fool1 month ago Biogen (BIIB) Stock Surges, But Real Blockbuster Is in the Pipeline  InvestorPlace.com1 month ago Did Biogen Run Too Much After Earnings?  24/7 Wall St1 month ago Here's Why Biogen Idec (BIIB) Stock Surged 7% After-Hours  Bidness Etc1 month ago
[x]  

The Catalysts Biogen Idec Investors Should Watch

Quarterly calls: Tecfidera sales number March 2015 - ADPD Conference: BIIB-037 Ph 1b mild / prodromal alzheimer's detailed data April 2015 (AAN Conference): Detailed LINGO (Optic Neuritis) Phase 2 data 1H15: Alprolix Kids B-Long Phase 3 data ...
 Benzinga.com1 week ago Biogen Idec Earnngs  Austin American Statesman1 month ago Tecfidera Sales Key for Biogen Idec — Earnings Preview  iMarketReports1 month ago

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 2, Authorised

This is a summary of the European public assessment report (EPAR) for Tecfidera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on ...
 European Medicines Agency2 months ago

Tecfidera, first-line oral treatment for multiple sclerosis, approved in India13-02-2015

US biotech major Biogen Idec's Indian subsidiary has received approval of the first oral therapy for… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , take ...
 Pharma Letter2 weeks ago Biogen gets approval of oral therapy for multiple sclerosis  ZeeNews.com3 weeks ago New oral treatment for multiple sclerosis approved for use in Canada  CTV News1 week ago PTI - BIOGEN (BCM15) - Biogen gets approval of oral therapy for multiple sclerosis  Namibia Press Agency3 weeks ago
[x]  

Alkermes Announces Positive Topline Results From Phase 1 Study of ALKS 8700 for Treatment of Multiple Sclerosis

Novel, Oral Product Candidate Provided Monomethyl Fumarate Exposures Comparable to TECFIDERA, With Favorable Gastrointestinal Tolerability Company Plans to Initiate Pivotal Development Program for Twice-Daily Candidate in 2015 DUBLIN--(BUSINESS ...
 BusinessWeek3 weeks ago Alkermes plc Announces Positive Topline Results From Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis  BioSpace3 weeks ago Alkermes plc (ALKS) Announces Positive Topline Results From Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis 2/9/2015  ClinicSpace3 weeks ago ALKERMES : Announces Positive Topline Results From Phase 1 Study of ALKS 8700 for Treatment of Multiple Sclerosis  4 Traders3 weeks ago
[x]  

Credit Suisse Previews Biogen, Says 'Consensus Tecfidera Downgrades = Pipeline Buying Opportunity'

Credit Suisse on Thursday previewed Biogen Idec Inc (NASDAQ: BIIB) ahead of its fourth-quarter results. Biogen is rated as Outperform with a $400 price target. In the report, analyst Ravi Mehrota wrote, "Consensus numbers for Tecfidera, in ...
 Benzinga.com1 month ago

Tecfidera and lymphocytes

12 February 2015 Author: Research has shown that people taking dimethyl fumarate (Tecfidera) have lower levels of subsets of lymphocytes (white blood cells). This may have a role in monitoring people on Tecfidera for risks of side effects. ...
 Multiple Sclerosis Trust2 weeks ago Oral MS treatment Tecfidera commissioned in Northern Ireland  Multiple Sclerosis Society3 weeks ago

Dazzling Tecfidera makes its Indian debut

Today Anju Ghangurde anju.ghangurde@informa.com ...
 Scrip3 weeks ago

Alkermes' multiple sclerosis prodrug looks good in Phase I, has Biogen Idec's Tecfidera in its sights

Alkermes ($ALKS) said the safety profile of its clinical-stage multiple sclerosis drug compares favorably to that of Biogen Idec's Tecfidera, citing the candidate's Phase I trial results on 104 patients. ALKS 8700's active ingredient (monomethyl ...
 Fierce Drug Delivery3 weeks ago Alkermes says its more tolerable Tecfidera rival is ready for pivotal challenge  FierceBiotech3 weeks ago Shares Of Biogen Jump 7% After Hours On Earnings, Increased Sales Of Multiple Sclerosis Drug  Tamar Securities1 month ago Biogen Idec expands North Carolina manufacturing operations  FiercePharmaManufacturing1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Tecfidera
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less